Share on LinkedInShare on LinkedIn

ARTICLE · 25 JUNE 2001

Experimental Use Exception – Clinical Trials In Germany

GermanyIntellectual Property
Heinz Goddar
Heinz Goddar

In Les Nouvelles, the author had discussed the consequences of a landmark decision of the German Federal Supreme Court, keyword "Clinical Trials II", published in 1997, relating to the extent of the experimental use exception according to Art. 11.2 of the German Patent Act, reading in translation essentially as follows:

"The rights conferred by the Patent shall not extend to acts done for experimental purposes relating to the subject-matter of the patented invention."

The German Federal Supreme Court (BGH) in the aforementioned decision had explicitly stated that clinical trials would be permitted even in cases where one of their purposes would be to obtain data for clinical approval, even if such trials would be conducted for the same indication as already known and protected, resp..

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from